[1]
J. Quintanilla, “Safety and Effectiveness of Lower Alteplase Dose Driven by Impending Clinical Deterioration Factors in very Elderly Submassive Pulmonary Embolism Patients. Case Series”, acmcr, vol. 6, no. 5, pp. 669–678, Oct. 2022.